Read + Share
Amedeo Smart
Independent Medical Education
Proto C, Manglaviti S, Lo Russo G, Musca M, et al. STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines. J Thorac Oncol 2023;18:1070-1081.PMID: 37094664
Email
LinkedIn
Facebook
Twitter
Privacy Policy